Cent
Latest round
- Series A
Last raised
- Oct 2026
Total raised
- $20M
Investors
- 8
About Cent
Based in India, Cent provides advanced healthcare solutions through its proprietary CCNM™ protocol, integrating diagnostic tools aimed at early detection of health risks and focusing on preventive care. Founded in 2025 by Arpit Garg, Shashank ND & Anshul Khandelwal in Bengaluru, India, CentAI Technologies Private Limited specializes in comprehensive healthcare solutions. Cent offers a comprehensive healthcare solution through its proprietary CCNM™ protocol, integrating full-body MRI, CT scans, genetic testing, and over 100 biomarkers. This approach targets more than 300 health conditions significantly contributing to preventable deaths, focusing on areas such as cancer, cardiac health, neuro health, and metabolic health. Advanced imaging technology and in-depth lab analyses allow Cent to generate detailed health reports assessing organ-level health and identifying potential risks. While primarily targeting the Indian market, Cent also serves health-conscious individuals seeking thorough preventive care and early detection of critical conditions, catering to a wide demographic from personal health seekers to families wanting comprehensive health screenings. Cent operates on a transactional revenue model, where customers pay directly for health checkup services without subscriptions or tiered packages. The flagship offering is the CCNM™ Scan, priced at INR 25,000, which includes a full-body scan with integrated AI-powered insights. Clients typically book appointments for these scans online or with a team, and services are conducted in a structured visit at Cent's facility. The straightforward payment structure emphasizes direct-to-consumer transactions, ensuring tailored health insights and consultations based on individual results. Following the scan, clients receive a comprehensive health report and a personalized consultation with medical specialists to discuss findings and recommendations. In the coming year, Cent plans to develop and launch new diagnostic products based on the CCNM™ protocol, aiming for release in late 2026. The company is also targeting expansion into additional regions within Asia, particularly Southeast Asia, by mid-2027.
Who invested in Cent
8 investors across 2 rounds
See all investors in Cent
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cent
Who invested in Cent?
Cent has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cent raised?
Cent has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cent last raise money?
Cent's most recent round on record is a Series A, in Oct 2026.
What does Cent do?
Based in India, Cent provides advanced healthcare solutions through its proprietary CCNM™ protocol, integrating diagnostic tools aimed at early detection of health risks and focusing on preventive care.
Where is Cent headquartered?
Cent is headquartered in Bangalore, India.
Which VCs invest in companies like Cent?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Cent's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Cent? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.